Cargando…

Ovarian stimulation in patients with breast cancer

Breast cancer is the most prevalent malignancy among women under 50. Improvements in diagnosis and treatment have yielded an important decrease in mortality in the last 20 years. In many cases, chemotherapy and radiotherapy develop side effects on the reproductive function. Therefore, before the ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muñoz, Elkin, González, Naira, Muñoz, Luis, Aguilar, Jesús, Velasco, Juan A García
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335970/ https://www.ncbi.nlm.nih.gov/pubmed/25729417 http://dx.doi.org/10.3332/ecancer.2015.504

Ejemplares similares

The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomized, double-blind, placebo-controlled trial(†)
por: Busso, Cristiano, et al.
Publicado: (2010)

Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic
por: Banker, Manish, et al.
Publicado: (2015)

Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patients
por: de Groot, Stefanie, et al.
Publicado: (2018)

Sentinel node biopsy in early breast cancer at the Hospital Comarcal La Linea (Spain)
por: Díaz Brito, Jack Antonio, et al.
Publicado: (2013)

Innovative perspectives in limbic surgery using deep brain stimulation
por: Carrillo-Ruiz, José Damián, et al.
Publicado: (2023)

Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective
por: Molina-Zayas, María, et al.
Publicado: (2022)

Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients
por: Sonigo, Charlotte, et al.
Publicado: (2019)

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.
por: Bronchud, M. H., et al.
Publicado: (1989)

The Influence of Therapeutic Exercise on Survival and the Quality of Life in Survivorship of Women with Ovarian Cancer
por: Sicardo Jiménez, Sebastián, et al.
Publicado: (2022)

The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
por: Shim, Yoo Jin, et al.
Publicado: (2018)

Gastrointestinal stromal tumors as an incidental finding in patients with a presumptive diagnosis of ovarian cancer
por: Muñoz, Mario, et al.
Publicado: (2012)

GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
por: González Martín, A., et al.
Publicado: (2013)

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
por: Derks-Smeets, Inge A. P., et al.
Publicado: (2018)

Randomised clinical trial of a manual therapy programme to reduce the evolution time of axillary web syndrome in women affected by breast cancer: study protocol
por: González Rubino, Jesús Baltasar, et al.
Publicado: (2022)

The Effect of Dose Adjustments in a Subsequent Cycle of Women With Suboptimal Response Following Conventional Ovarian Stimulation
por: Drakopoulos, Panagiotis, et al.
Publicado: (2018)

Machine Learning Quantification of Intraepithelial Tumor-Infiltrating Lymphocytes as a Significant Prognostic Factor in High-Grade Serous Ovarian Carcinomas
por: Machuca-Aguado, Jesús, et al.
Publicado: (2023)

Acetylcholine, Another Factor in Breast Cancer
por: Muñoz, Juan P., et al.
Publicado: (2023)

Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2020)

The genetics of breast and ovarian cancer.
por: Ford, D., et al.
Publicado: (1995)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

Efficacy of Random-start Controlled Ovarian Stimulation in Cancer Patients
por: Kim, Jee Hyun, et al.
Publicado: (2015)

Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer
por: Thompson, Ella R., et al.
Publicado: (2013)

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
por: Muñoz-Couselo, Eva, et al.
Publicado: (2011)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Management of advanced ovarian cancer in Spain: an expert Delphi consensus
por: Redondo, Andres, et al.
Publicado: (2021)

Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients
por: Campos, Ana Paula CB, et al.
Publicado: (2018)

Random‐start ovarian stimulation with aromatase inhibitor for fertility preservation in women with Japanese breast cancer
por: Nakasuji, Takashi, et al.
Publicado: (2019)

Comparison of mild ovarian stimulation with conventional ovarian stimulation in poor responders
por: Yoo, Ji Hee, et al.
Publicado: (2011)

Deletion at 6q24.2–26 predicts longer survival of high‐grade serous epithelial ovarian cancer patients
por: Kamieniak, Marta M., et al.
Publicado: (2014)

Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
por: Nañez, Andrea, et al.
Publicado: (2021)

Familial Breast and Ovarian Cancer
por: Spence, R A J
Publicado: (2003)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2021)

Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells
por: Desir, Snider, et al.
Publicado: (2016)

Morphological and phenotypical features of ovarian metastases in breast cancer patients
por: Peters, Inge T. A., et al.
Publicado: (2017)

Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients
por: Tamkovich, Svetlana N, et al.
Publicado: (2019)

Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients
por: Rothé, Françoise, et al.
Publicado: (2021)

The effectiveness of controlled ovarian stimulation with tamoxifen for patients with estrogen‐sensitive breast cancer: A systematic review and meta‐analysis
por: Yoshida, Tsukasa, et al.
Publicado: (2023)

Pharmaceutical care for patients with breast and ovarian cancer
por: Liekweg, Andrea, et al.
Publicado: (2012)

Translation, Cross-Cultural Adaptation and Validation of the Myofascial Adhesions for Patients after Breast Cancer (MAP-BC) Evaluation Tool: Spanish Version
por: Casuso-Holgado, María Jesús, et al.
Publicado: (2022)

Ovarian reserve parameters and response to controlled ovarian stimulation in infertile patients
por: Siddiqui, Qurat ul Aman, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4uus4jgep7sh35g4monuspctp5